Tech Center 1700 • Art Units: 1652 1799
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16973061 | CRISPR EFFECTOR SYSTEM BASED AMPLIFICATION METHODS, SYSTEMS, AND DIAGNOSTICS | Final Rejection | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 17786913 | BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS | Final Rejection | The Regents of the University of California |
| 17998703 | IMPROVED METHOD FOR THE PRODUCTION OF ISOPRENOIDS | Final Rejection | BASF SE |
| 18297366 | DETERGENT COMPOSITIONS CONTAINING ENZYMES | Final Rejection | The Procter & Gamble Company |
| 16771794 | USE OF A COMBINATION OF TET EXOPROTEASES OBTAINED FROM EXTREMOPHILIC MICROORGANISMS FOR HYDROLYZING POLYPEPTIDES | Final Rejection | UNIVERSITE GRENOBLE ALPES |
| 17331883 | Engineered CRISPR-Cas9 Nucleases | Final Rejection | The General Hospital Corporation |
| 17924145 | GENETICALLY MODIFIED MICROORGANISM AND METHOD FOR PRODUCING ORGANIC ACID | Final Rejection | TORAY INDUSTRIES, INC. |
| 18402269 | DECOLORIZING COMPOSITION INCLUDING DICYANDIAMIDE AND HYDROGEN PEROXIDE AND DECOLORIZING METHOD USING THE SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 17459166 | ENGINEERED PROTEINS AND METHODS OF USE THEREOF | Non-Final OA | Pairwise Plants Services, Inc. |
| 18718677 | PRODUCTION OF ALPHA-1,3-FUCOSYLATED COMPOUNDS | Non-Final OA | INBIOSE N.V. |
| 17961007 | BACILLUS GIBSONII-CLADE SERINE PROTEASES | Final Rejection | Danisco US Inc. |
| 18035610 | METHOD FOR ENZYMATIC OXIDATION OF SULFINIC ACIDS TO SULFONIC ACIDS | Final Rejection | WACKER CHEMIE AG |
| 16450699 | NOVEL CRISPR ENZYMES AND SYSTEMS | Non-Final OA | The United States of America, as Represented by the Secretary, Dept. of Health and Human Services |
| 16450852 | NOVEL CRISPR ENZYMES AND SYSTEMS | Final Rejection | The United States of America, as Represented by the Secretary, Dept. of Health and Human Services |
| 16450825 | NOVEL CRISPR ENZYMES AND SYSTEMS | Final Rejection | The United States of America, as Represented by the Secretary, Dept. of Health and Human Services |
| 18627530 | GENETICALLY ENGINEERED BACTERIUM USING GLUCOSE AS SUBSTRATE FOR DE NOVO SYNTHESIS OF VANILLIN AND APPLICATION THEREOF | Final Rejection | Beijing University of Chemical Technology |
| 18013047 | Improved Export of Oligosaccharides From Bacterial Cells | Non-Final OA | Chr. Hansen A/S |
| 18501492 | SYSTEM AND METHOD FOR PRODUCING A SUGAR STREAM | Non-Final OA | Fluid Quip Technologies, LLC |
| 18501501 | METHOD FOR PRODUCING A SUGAR STREAM | Non-Final OA | Fluid Quip Technologies, LLC |
| 18242912 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS | Non-Final OA | Genomatica, Inc. |
| 18548429 | NOVEL CRISPR-CAS NUCLEASES FROM METAGENOMES | Non-Final OA | Brain Biotech AG |
| 18548325 | INSECT-DERIVED ASPARTATE DECARBOXYLASES AND VARIANTS THEREOF FOR IMPROVED BETA-ALANINE PRODUCTION | Non-Final OA | MOJIA BIOTECH LTD. |
| 17911409 | BIO-BASED NYLON PRECURSORS HAVING REDUCED ORGANIC AND INORGANIC IMPURITIES | Non-Final OA | MOJIA BIOTECH LTD. |
| 17277585 | PROCESS FOR CONTROLLING A FERMENTATION PROCESS | Non-Final OA | FermentationExperts A/S |
| 18033787 | Novel Variants of Endonuclease V and Uses Thereof | Non-Final OA | DNA Script |
| 18003025 | PICHIA CIFERRII MUTANT STRAIN HAVING IMPROVED SPHINGOLIPID AND SPHINGOID BASE PRODUCTIVITY, AND PREPARATION METHOD THEREFOR | Non-Final OA | Croda Korea Ltd |
| 17926572 | PROCESS FOR EXTRACTING A HYALURONIC ACID FROM A FUNGUS, A HYALURONIC ACID OF PLANT ORIGIN AND USE THEREOF | Final Rejection | VIVATIS PHARMA GMBH |
| 17270690 | Method for Producing Biodegradable Polymer | Non-Final OA | MOHARRAM VENTURES INC. |
| 15561524 | EXPRESSION SYSTEM AND USES THEREOF | Non-Final OA | SELEXIS S.A. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy